Stay updated on Lebrikizumab Safety & Efficacy in Adolescent AD Clinical Trial
Sign up to get notified when there's something new on the Lebrikizumab Safety & Efficacy in Adolescent AD Clinical Trial page.

Latest updates to the Lebrikizumab Safety & Efficacy in Adolescent AD Clinical Trial page
- Check4 days agoChange DetectedThe government funding/operating status notice was removed; the study details and enrollment information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe changes appear to be minor UI/layout adjustments with no substantive changes to core study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check47 days agoChange DetectedUpdated version to v3.2.0 and added a government operating-status notice for NIH Clinical Center, directing users to cc.nih.gov and opm.gov.SummaryDifference2%

- Check54 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

- Check68 days agoChange DetectedUpdated revision to v3.0.2 and removed the 'Back to Top' element. Overall, core content remains unchanged.SummaryDifference0.1%

- Check76 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.1%

Stay in the know with updates to Lebrikizumab Safety & Efficacy in Adolescent AD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lebrikizumab Safety & Efficacy in Adolescent AD Clinical Trial page.